Literature DB >> 27188986

Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum.

Carlo Wilke1, Oliver Preische2, Christian Deuschle1, Benjamin Roeben1, Anja Apel1, Christian Barro3, Luis Maia4, Walter Maetzler1, Jens Kuhle3, Matthis Synofzik1.   

Abstract

Entities:  

Keywords:  ALS; CSF; DEMENTIA; FRONTAL LOBE

Mesh：

Substances：

Year:  2016        PMID： 27188986     DOI： 10.1136/jnnp-2015-312972

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  30 in total

1.  Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study.

Authors:  Carlo Wilke; Friedemann Bender; Stefanie N Hayer; Kathrin Brockmann; Ludger Schöls; Jens Kuhle; Matthis Synofzik
Journal:  J Neurol       Date:  2018-05-08       Impact factor: 4.849

2.  Fluid Biomarkers of Frontotemporal Lobar Degeneration.

Authors:  Emma L van der Ende; John C van Swieten
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.

Authors:  Daniela Rossi; Paolo Volanti; Liliana Brambilla; Tiziana Colletti; Rossella Spataro; Vincenzo La Bella
Journal:  J Neurol       Date:  2018-01-10       Impact factor: 4.849

4.  Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophy.

Authors:  Ignacio Illán-Gala; Victor Montal; Sergi Borrego-Écija; Eduard Vilaplana; Jordi Pegueroles; Daniel Alcolea; Belén Sánchez-Saudinós; Jordi Clarimón; Janina Turón-Sans; Nuria Bargalló; Sofía González-Ortiz; Howard J Rosen; Maria Luisa Gorno-Tempini; Bruce L Miller; Albert Lladó; Ricard Rojas-García; Rafael Blesa; Raquel Sánchez-Valle; Alberto Lleó; Juan Fortea
Journal:  Brain       Date:  2019-04-01       Impact factor: 13.501

Review 5.  The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.

Authors:  Filippo Baldacci; Sonia Mazzucchi; Alessandra Della Vecchia; Linda Giampietri; Nicola Giannini; Maya Koronyo-Hamaoui; Roberto Ceravolo; Gabriele Siciliano; Ubaldo Bonuccelli; Fanny M Elahi; Andrea Vergallo; Simone Lista; Filippo Sean Giorgi; Harald Hampel
Journal:  Expert Rev Mol Diagn       Date:  2020-02-27       Impact factor: 5.225

Review 6.  The role of neurofilament light chain in frontotemporal dementia: a meta-analysis.

Authors:  Eleni Karantali; Dimitrios Kazis; Symela Chatzikonstantinou; Fivos Petridis; Ioannis Mavroudis
Journal:  Aging Clin Exp Res       Date:  2020-04-18       Impact factor: 3.636

Review 7.  Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders.

Authors:  Zahra Alirezaei; Mohammad Hossein Pourhanifeh; Sarina Borran; Majid Nejati; Hamed Mirzaei; Michael R Hamblin
Journal:  Mol Neurobiol       Date:  2019-08-05       Impact factor: 5.590

Review 8.  Blood Biomarkers for Alzheimer's Disease: Much Promise, Cautious Progress.

Authors:  Ashvini Keshavan; Amanda Heslegrave; Henrik Zetterberg; Jonathan M Schott
Journal:  Mol Diagn Ther       Date:  2017-02       Impact factor: 4.074

Review 9.  Imaging and fluid biomarkers in frontotemporal dementia.

Authors:  Lieke H Meeter; Laura Donker Kaat; Jonathan D Rohrer; John C van Swieten
Journal:  Nat Rev Neurol       Date:  2017-06-16       Impact factor: 42.937

10.  Neurofilament light as a biomarker in traumatic brain injury.

Authors:  Pashtun Shahim; Adam Politis; Andre van der Merwe; Brian Moore; Yi-Yu Chou; Dzung L Pham; John A Butman; Ramon Diaz-Arrastia; Jessica M Gill; David L Brody; Henrik Zetterberg; Kaj Blennow; Leighton Chan
Journal:  Neurology       Date:  2020-07-08       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.